C. Stephens

发表

Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agents.

J. Perfect, W. Wilson, D. Boykin, 2001, Journal of medicinal chemistry.

Diguanidino and “Reversed” Diamidino 2,5‐Diarylfurans as Antimicrobial Agents.

J. Perfect, W. Wilson, D. Boykin, 2001 .

In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi.

D. Boykin, A. Romanha, A. Junqueira, 2011, The Journal of antimicrobial chemotherapy.

Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro.

Arvind Kumar, D. Boykin, C. E. Stephens, 2009, Experimental parasitology.

Detection of Inhibition of Bovine Viral Diarrhea Virus by Aromatic Cationic Molecules

Arvind Kumar, D. Boykin, D. Stringfellow, 2003, Antimicrobial Agents and Chemotherapy.

Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.

C. Bailly, W. Wilson, Arvind Kumar, 2002, Cancer research.

Synthesis of Benzyloxybromobenzonitriles

D. Boykin, C. E. Stephens, M. Ismail, 2004 .

Synthesis of Benzyloxybromobenzonitriles.

D. Boykin, M. Ismail, M. Anbazhagan, 2004 .

Identification of diphenyl furan derivative via high throughput and computational studies as ArgA inhibitor of Mycobacterium tuberculosis.

Ramandeep Singh, D. Chaudhary, T. Maiti, 2021, International journal of biological macromolecules.

Activities of Dicationic Compounds against Trichomonas vaginalis

Arvind Kumar, D. Boykin, W. Secor, 2004, Antimicrobial Agents and Chemotherapy.

The activity of diguanidino and 'reversed' diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani.

W. Wilson, D. Boykin, R. Brun, 2003, Bioorganic & medicinal chemistry letters.

Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.

Daniel P. Sweat, P. Peixoto, W. Wilson, 2019, Journal of medicinal chemistry.

Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines

P. Peixoto, Arvind Kumar, D. Boykin, 2012, Nucleic acids research.

Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity.

W. Wilson, Binh Nguyen, D. Boykin, 2005, Current medicinal chemistry. Anti-cancer agents.

Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones.

E. De Clercq, J. Balzarini, E. Clercq, 2001, Bioorganic & medicinal chemistry.

Synthesis and antiparasitic evaluation of bis-2,5-[4-guanidinophenyl]thiophenes.

W. Wilson, D. Boykin, R. Brun, 2007, European journal of medicinal chemistry.

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo

L. Partridge, A. Chiò, H. Zetterberg, 2017, EMBO molecular medicine.

The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures

D. Boykin, C. Kropf, A. Hemphill, 2011, Parasitology.

In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cells

D. Boykin, A. Hemphill, C. E. Stephens, 2011, Parasitology.

Synthesis and charge density determination of 4,4-difluoro-3,5-diphenyl-4H-pyrazole and a hydrate derivative

J. Bacsa, C. E. Stephens, C. K. Eidell, 2015 .

UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE

L. Trepanier, D. Boykin, J. R. Kurian, 2005, Drug Metabolism and Disposition.

Novel Arylimidamides for Treatment of Visceral Leishmaniasis

R. Madhubala, D. Kyle, W. Wilson, 2010, Antimicrobial Agents and Chemotherapy.

Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

D. Boykin, A. Romanha, A. Junqueira, 2010, Antimicrobial Agents and Chemotherapy.

A quantitative reverse-transcriptase PCR assay for the assessment of drug activities against intracellular Theileria annulata schizonts

Joachim Müller, A. Hemphill, C. E. Stephens, 2014, International journal for parasitology. Drugs and drug resistance.

In Vitro and In Vivo Activities of Dicationic Diguanidino Compounds against Echinococcus multilocularis Metacestodes

D. Boykin, A. Hemphill, C. E. Stephens, 2013, Antimicrobial Agents and Chemotherapy.

In Vitro Efficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes

J. Keiser, D. Boykin, C. Kropf, 2011, Antimicrobial Agents and Chemotherapy.

Inhibitory effect of dicationic diphenylfurans on production of type I collagen by human fibroblasts and activated hepatic stellate cells.

B. Stefanovic, D. Boykin, C. E. Stephens, 2005, Life sciences.

Antiprion Activity of DB772 and Related Monothiophene- and Furan-Based Analogs in a Persistently Infected Ovine Microglia Culture System

D. Boykin, C. E. Stephens, D. Schneider, 2016, Antimicrobial Agents and Chemotherapy.

Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection

D. Boykin, C. E. Stephens, A. Farahat, 2017, Drug Design, Development and Therapy.

Mono- and trifluorination of the thiazole ring of 2,5-diarylthiazoles using N-fluorobenzenesulfonimide (NFSI)

C. E. Stephens, Julie M. Hatfield, C. K. Eidell, 2013 .

Distribution of furamidine analogues in tumor cells: influence of the number of positive charges.

C. Bailly, W. Wilson, Arvind Kumar, 2002, Journal of medicinal chemistry.

DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site.

W. Wilson, Arvind Kumar, D. Boykin, 2010, Journal of molecular biology.

Evaluation of Arylimidamides DB1955 and DB1960 as Candidates against Visceral Leishmaniasis and Chagas' Disease: In Vivo Efficacy, Acute Toxicity, Pharmacokinetics, and Toxicology Studies

W. Wilson, D. Boykin, Qiang Liu, 2012, Antimicrobial Agents and Chemotherapy.

CYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]

D. Boykin, D. Zeldin, J. Hall, 2006, Drug Metabolism and Disposition.

Inhibition by Dications of In Vitro Growth of Leishmania major and Leishmania tropica: Causative Agents of Old World Cutaneous Leishmaniasis

Arvind Kumar, D. Boykin, J. Hall, 2008, The Journal of parasitology.

Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".

D. Boykin, C. E. Stephens, C. F. Silva, 2007, Biochemical pharmacology.

A modified synthesis of tellurophene using NaBH4 to generate sodium telluride

Daniel P. Sweat, C. E. Stephens, C. Stephens, 2008 .

Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.

D. Boykin, Lianwen Zhou, J. Hall, 2002, Rapid communications in mass spectrometry : RCM.

CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.

D. Boykin, J. Hall, R. Tidwell, 2014, Journal of pharmaceutical sciences.

Oxidative ring opening of 2,5-diarylfurans by Selectfluor®

C. E. Stephens, Stephen J. Blank, C. Stephens, 2006 .

Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines

Shuo Wang, W. Wilson, Arvind Kumar, 2013, Nucleic acids research.

Large, sequence-dependent effects on DNA conformation by minor groove binding compounds

W. Wilson, Arvind Kumar, D. Boykin, 2009, Nucleic acids research.

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo

D. Boykin, C. E. Stephens, C. Britto, 2011, PloS one.